Department of Primary and Community Care, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J Clin Epidemiol. 2024 Oct;174:111505. doi: 10.1016/j.jclinepi.2024.111505. Epub 2024 Aug 17.
Persistent somatic symptoms (PSS) describe recurrent or continuously occurring symptoms such as fatigue, dizziness, or pain that have persisted for at least several months. These include single symptoms such as chronic pain, combinations of symptoms, or functional disorders such as fibromyalgia or irritable bowel syndrome. While many studies have explored stigmatisation by healthcare professionals toward people with PSS, there is a lack of validated measurement instruments. We recently developed a stigma scale, the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP). The aim of this study is to evaluate the measurement properties (validity and reliability) and factor structure of the PSSS-HCP.
The PSSS-HCP was tested with 121 healthcare professionals across the United Kingdom to evaluate its measurement properties. Analysis of the factor structure was conducted using principal component analysis. We calculated Cronbach's alpha to determine the internal consistency of each (sub)scale. Test-retest reliability was conducted with a subsample of participants with a 2-week interval. We evaluated convergent validity by testing the association between the PSSS-HCP and the Medical Condition Regard Scale (MCRS) and the influence of social desirability using the short form of the Marlowe-Crowne Social Desirability Scale (MCSDS).
The PSSS-HCP showed sufficient internal consistency (Cronbach's alpha = 0.84) and sufficient test-retest reliability, intraclass correlation = 0.97 (95% CI 0.94-0.99, P < .001). Convergent validity was sufficient between the PSSS-HCP and the MCRS, and no relationship was found between the PSSS-HCP and the MCSDS. A three factor structure was identified (othering, uneasiness in interaction, non-disclosure) which accounted for 60.5% of the variance using 13 of the 19 tested items.
The PSSS-HCP can be used to measure PSS stigmatisation by healthcare professionals. The PSSS-HCP has demonstrated sufficient internal consistency, test-retest reliability, convergent validity and no evidence of social desirability bias. The PSSS-HCP has demonstrated potential to measure important aspects of stigma and provide a foundation for stigma reduction intervention evaluation.
持续性躯体症状(PSS)描述反复发作或持续存在的症状,如疲劳、头晕或疼痛,这些症状至少持续数月。这些症状包括慢性疼痛等单一症状、多种症状的组合或纤维肌痛或肠易激综合征等功能性障碍。虽然许多研究都探讨了医疗保健专业人员对 PSS 患者的污名化问题,但缺乏经过验证的测量工具。我们最近开发了一种污名量表,即医疗保健专业人员持续性躯体症状污名量表(PSSS-HCP)。本研究的目的是评估 PSSS-HCP 的测量特性(有效性和可靠性)和因素结构。
在英国,我们对 121 名医疗保健专业人员进行了 PSSS-HCP 测试,以评估其测量特性。使用主成分分析进行因素结构分析。我们计算了 Cronbach's alpha 以确定每个(子)量表的内部一致性。使用参与者的子样本进行了 2 周间隔的测试 - 重测信度。我们通过测试 PSSS-HCP 与医疗状况关注量表(MCRS)之间的相关性以及使用 Marlowe-Crowne 社会期望量表(MCSDS)短版评估社会期望的影响来评估聚合效度。
PSSS-HCP 显示出足够的内部一致性(Cronbach's alpha = 0.84)和足够的测试 - 重测信度,组内相关系数= 0.97(95%CI 0.94-0.99,P < 0.001)。PSSS-HCP 与 MCRS 之间的聚合效度足够,而 PSSS-HCP 与 MCSDS 之间没有关系。使用 19 个测试项目中的 13 个,确定了三个因素结构(他者化、互动时的不适、不披露),占方差的 60.5%。
PSSS-HCP 可用于衡量医疗保健专业人员对 PSS 的污名化。PSSS-HCP 已证明具有足够的内部一致性、测试 - 重测信度、聚合效度,且不存在社会期望偏差的证据。PSSS-HCP 有潜力测量污名的重要方面,并为减少污名干预评估提供基础。